Management Change – Form 8-K
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
|
|
1-6028 |
35-1140070 |
||
|
(State or other jurisdiction |
(Commission |
( |
||
|
of incorporation) |
File Number) |
Identification No.) |
(Address of principal executive offices) (
Registrant's telephone number, including area code: (484) 583-1400
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
__________________________________
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class |
Trading symbol(s) |
|
|
Common Stock |
LNC |
|
|
Depositary Shares, each representing a 1/1000th interest in a share of 9.000% Non-Cumulative Preferred Stock, Series D |
LNC PRD |
|
__________________________________
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On
The material terms and conditions of the 2020 Plan are described in the Company's Proxy Statement filed with the
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On
The foregoing summary of the Bylaws does not purport to be complete and is qualified in its entirety by reference to the full text of the Bylaws attached hereto as Exhibit 3.1 and incorporated herein by reference.
Item 5.07. Submission of Matters to a Vote of Security Holders.
The Company's 2023 Annual Meeting was held on
Item 1.Election of Directors
The eleven nominees for election to the Board were elected, each for a term expiring at the Company's 2024 Annual Meeting of Shareholders, based upon the following votes:
|
Director Nominee |
For |
Against |
Abstentions |
Broker Non-Votes |
|
|
109,192,183 |
8,807,341 |
548,287 |
23,929,526 |
|
|
106,456,237 |
8,032,918 |
4,058,655 |
23,929,526 |
|
|
109,166,112 |
8,672,063 |
709,636 |
23,929,526 |
|
|
115,084,389 |
2,982,214 |
481,207 |
23,929,526 |
|
|
109,358,505 |
8,716,982 |
472,324 |
23,929,526 |
|
|
111,321,832 |
6,720,426 |
505,554 |
23,929,526 |
|
|
109,986,289 |
7,951,542 |
609,980 |
23,929,526 |
|
|
115,094,886 |
2,943,486 |
509,439 |
23,929,526 |
|
|
113,792,466 |
4,275,012 |
480,333 |
23,929,526 |
|
|
109,808,725 |
8,020,705 |
718,381 |
23,929,526 |
|
|
115,787,547 |
2,250,315 |
509,949 |
23,929,526 |
Item 2.Ratification of Auditors
The proposal to ratify the appointment of
|
For |
Against |
Abstentions |
|
133,633,920 |
8,143,987 |
699,430 |
There were no broker non-votes for this item.
Item 3.Advisory Resolution on Executive Compensation
The proposal to approve an advisory resolution regarding the compensation paid to the Company's named executive officers, as disclosed in the Company's 2023 Proxy Statement, was approved based on the following votes:
|
For |
Against |
Abstentions |
Broker Non-Votes |
|
92,923,253 |
24,621,844 |
1,002,714 |
23,929,526 |
Item 4.Advisory Proposal Regarding Frequency of Future Advisory Resolutions on Executive Compensation
A one-year frequency was approved, on an advisory basis, with respect the proposal regarding the frequency (every one, two or three years) of future advisory resolutions on the compensation of the Company's named executive officers, based on the following votes:
|
One Year |
Two Years |
Three Years |
Abstentions |
Broker Non-Votes |
|
114,524,883 |
314,809 |
2,538,389 |
581,573 |
24,512,977 |
Item 5.Approval of Amendment to
The proposal to approve the Amendment to the 2020 Plan was approved based on the following votes:
|
For |
Against |
Abstentions |
Broker Non-Votes |
|
82,569,774 |
35,131,526 |
846,511 |
23,929,526 |
Item 6.Non-Binding Shareholder Proposal Regarding Independent Board Chair
The non-binding shareholder proposal to amend the Company's corporate governance documents to require an independent board chair was not approved based on the following votes:
|
For |
Against |
Abstentions |
Broker Non-Votes |
|
54,622,341 |
63,173,840 |
751,630 |
23,929,526 |
Item 7.Non-Binding Shareholder Proposal Regarding Ratification of Executive Termination Pay
The non-binding shareholder proposal requesting that the Board seek shareholder approval or ratification of new or renewed executive pay packages that provide for severance or termination payments with an estimated value exceeding 2.99 times the sum of the executive's base salary plus short-term bonus was not approved based on the following votes:
|
For |
Against |
Abstentions |
Broker Non-Votes |
|
18,543,483 |
99,330,674 |
668,949 |
23,929,526 |
Item 9.01. Financial Statements and Exhibits.
|
(c) |
Exhibits. |
|
Exhibit Number |
Description |
|
3.1 |
Amended and Restated Bylaws of the Company, effective |
|
10.1* |
|
|
104 |
Cover Page Interactive Data File (embedded with the Inline XBRL document). |
_____________
* This exhibit is a management contract or a compensatory plan or arrangement.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|||||
|
By |
/s/ |
||||
|
|
|
||||
|
Title: |
Senior Vice President and Secretary |
Date:
Attachments
Disclaimer


Ipsen receives CHMP negative opinion, following re-examination of potential first FOP treatment in the E.U.
Where the boys aren't — college graduations
Advisor News
- How much could failure to fund Social Security cost average Americans?
- How can more Americans achieve financial independence?
- Savers vs. spenders: How money management attitudes impact financial confidence
- Demonstrating the value of life insurance to Gen Z
- Poor money habits are a dealbreaker in a new relationship
More Advisor NewsAnnuity News
- Canvas steps into the direct-to-consumer market that has yet to take off
- The next growth phase in life/annuities depends on modernization
- CA judge certifies class action in teachers’ lawsuit over in-plan annuity fees
- Globe Life Inc. (NYSE: GL) Records 52-Week High Thursday Morning
- AM Best Managing Director Joins ‘Target Topics’ Podcast to Discuss State of Delegated Underwriting Authority Enterprises Market
More Annuity NewsHealth/Employee Benefits News
- A Tale of Two Behavioral Health Systems, or How the State Border Determines Who Gets Access to Mental Healthcare
- Recent Findings from Iwate Medical University Provide New Insights into Science (Nonlinear Associations Between Sleep Duration and Incident LTCI Certification in Older Adults: Findings From the Iwate-Kenpoku Cohort Study): Science
- Researchers from Capital Medical University Detail New Studies and Findings in the Area of Managed Care (Factors Contributing To the Enrollment of Ambiguous Medical Insurance Cases: a Retrospective Study At a Tertiary Hospital In Beijing): Managed Care
- Studies from Cornell University Further Understanding of Managed Care (IRA Reforms To Medicare Part D Reinsurance Were Associated With Plan Exits And Higher Premiums, 2024-25): Managed Care
- New Managed Care Study Results from Yale University School of Medicine Described (Establishing Neonatal Toxicology Testing Protocols to Prioritize Clinical Utility Reduces Racial and Socioeconomic Bias): Managed Care
More Health/Employee Benefits NewsLife Insurance News
- USAA introduces Secure Start whole life program for children
- Best’s Market Segment Report: AM Best Maintains Stable Outlook on South Korea’s Non-Life Insurance Market
- Horace Mann Strengthens Customer Relationships and Accelerates Long-Term Growth Through Transactions with Medical Mutual of Ohio
- Regulators: ‘No firm conclusions’ from first offshore reinsurance filings
- Allianz Life Study Finds Americans Struggle to Shift From Retirement Saving to Spending
More Life Insurance News